Page last updated: 2024-08-24

thiazolyl blue and Epstein-Barr Virus Infections

thiazolyl blue has been researched along with Epstein-Barr Virus Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donovan, J; Huang, D; Li, JH; Liu, FF; Weinrib, L1

Other Studies

1 other study(ies) available for thiazolyl blue and Epstein-Barr Virus Infections

ArticleYear
Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Cancer gene therapy, 2001, Volume: 8, Issue:5

    Topics: Adenoviridae; Antineoplastic Agents; beta-Galactosidase; Blotting, Western; Cell Survival; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Gene Expression; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53

2001